Oncología de precisión en el CPNM con mutación de HER2: Estrategias para hoy y mañana

Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow Authors: Yong Fang, MD; Hye Ryun Kim, MD, PhD; Hibiki Udagawa, MD, PhD https://www.medscape.org/viewarticle/precision-oncology-her2-mutated-nsclc-strategies-today-and-2025a100105r?page=2&subtitle-lang-code=es&ecd=mkm_ret_260606_mscpmrk-ES_CME_etid8393469&uac=148436CN&impID=8393469